Age-Specific Sex-Based Differences in Anemia in Patients with Myocardial Infarction

Vojko Kanic1, Gregor Kompara1, Maja Vollrath2

  • 11Department of Cardiology and Angiology, University Medical Center Maribor, Maribor, Slovenia.

Insights

Younger women with myocardial infarction (MI) experience higher rates of anemia than men, and anemia is linked to worse outcomes. These sex-based differences in anemia prevalence and outcomes are crucial for understanding mortality in MI patients undergoing percutaneous coronary intervention (PCI).

Area of Science:

  • Cardiology
  • Hematology
  • Gerontology

Background:

  • Anemia prevalence and its association with outcomes in myocardial infarction (MI) patients undergoing percutaneous coronary intervention (PCI) may differ by age and sex.
  • Limited data exists on age-specific, sex-based variations in anemia among MI patients and their impact on prognosis.

Purpose of the Study:

  • To investigate age-specific sex-based differences in anemia on admission and discharge in MI patients treated with PCI.
  • To assess the association of these anemia differences with 30-day and long-term all-cause mortality.

Main Methods:

  • Analysis of data from 5579 MI patients (31.0% women) who underwent PCI.
  • Comparison of anemia prevalence and its association with mortality between men and women across different age groups.
  • Descriptive statistical analysis to evaluate outcomes.

Main Results:

  • Women had a higher prevalence of anemia than men (37.5% vs. 26.8%, p < 0.0001).
  • Anemia prevalence increased with age in men but showed a J-shaped relationship in women.
  • Anemia on admission and discharge predicted higher 30-day and long-term mortality in both sexes.
  • Women had a better adjusted long-term prognosis overall (HR=0.78, p < 0.0001).

Conclusions:

  • Age-specific sex-based differences in anemia exist in MI patients undergoing PCI, with younger women experiencing higher rates.
  • Anemia is a significant predictor of adverse outcomes, including 30-day and long-term mortality, in this patient population.
  • Understanding these sex-based disparities in anemia is vital for explaining sex-related mortality differences in MI patients undergoing PCI.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
235
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
701
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
259
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
253
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
108.7K